VIVEVE MED INC
VIVE
VIVE was delisted on the 18th of January, 2023.
16 hedge funds and large institutions have $216K invested in VIVEVE MED INC in 2022 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 0 closing their positions.
7% more funds holding
Funds holding: 15 → 16 (+1)
42% less capital invested
Capital invested by funds: $374K → $216K (-$158K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$1.51K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$515 |
| 3 |
Wells Fargo
San Francisco,
California
|
+$1 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$27K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$341 |
| 3 |
Renaissance Technologies
New York
|
-$202 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$97 |
| 5 |
Bank of New York Mellon
New York
|
-$50 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
BlackRock
New York
| $104K | – | – | – |
|
|
2
Vanguard Group
Malvern,
Pennsylvania
| $25.6K | -$27K | -53,667 | -47% |
|
3
State Street
Boston,
Massachusetts
| $23.3K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $21K | – | – | – |
|
|
5
Renaissance Technologies
New York
| $14K | -$202 | -400 | -1% |
|
6
Northern Trust
Chicago,
Illinois
| $7.26K | – | – | – |
|
|
TSS
7
Two Sigma Securities
New York
| $6.13K | +$515 | +1,022 | +8% |
|
|
8
Bank of New York Mellon
New York
| $5.47K | -$50 | -100 | -0.8% |
|
|
QPWM
9
Quadrant Private Wealth Management
Center Valley,
Pennsylvania
| $4.25K | +$5.04K | +10,000 | New |
|
|
10
Osaic Holdings
Scottsdale,
Arizona
| $3K | +$1.51K | +3,000 | +120% |
|
|
11
UBS Group
Zurich,
Switzerland
| $1.19K | -$341 | -677 | -20% |
|
|
TRCT
12
Tower Research Capital (TRC)
New York
| $1K | -$97 | -193 | -7% |
|
|
13
Wells Fargo
San Francisco,
California
| $31 | +$1 | +2 | +3% |
|
14
Fidelity Investments
Boston,
Massachusetts
| $21 | – | – | – |
|
15
Morgan Stanley
New York
| $1 | -$5 | -10 | -83% |
|
VIVE Hedge Fund Activity: Q4 2022 in Review
16 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in VIVEVE MED INC (VIVE) for Q4 2022, worth a combined $216K — down 42% from $374K a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new VIVE positions and 0 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Osaic Holdings, adding an estimated $1.51K. The largest seller was Vanguard Group, cutting an estimated $27K.
- 16 institutional investors held VIVEVE MED INC (VIVE) as of Q4 2022, up from 15 in Q3 2022.
- Funds reported $216K of VIVEVE MED INC stock for Q4 2022, down 42% quarter-over-quarter.
- 1 fund opened new VIVEVE MED INC positions in Q4 2022 and 0 closed out, a net change of +1 holder.
- The largest VIVEVE MED INC buyer in Q4 2022 was Osaic Holdings, an estimated $1.51K added.
- The largest VIVEVE MED INC seller in Q4 2022 was Vanguard Group, an estimated $27K sold.
Based on aggregated 13F filings for Q4 2022.